Hello all, Codename SCNR v1.5 and Codename RKN 1.4 have just been released, both now with support for incremental scans. This means that a scan session is maintained and the following workflow is now possible: Run initial/seed scan. Store its session in a file. Run a re-scan, auditing only newly introduced input vectors, i.e. continuing a previous session. Store its session in a file. And so on and so forth. This has the massive advantage of re-scans being immensely quick, as they will only concern themselves with newly introduced input vectors, rather than being full dumb scans again and again....
Hello all, I would like to introduce to you the new addition to Ecsypno's product line: Codename RKN Codename RKN is the first comprehensive WebApp attack surface mapper. It can help save countless hours from your daily duties by providing amazing insight into a web application's behavior and inner workings. It utilizes DAST and client-side IAST techniques to monitor everything about a black-box and presents its I/O characteristics in an approachable form. Codename RKN digs deep and will let you know how to prepare your penetration test approach for each web application based on how it processes its inputs and...
Hello all, I am very pleased to announce the commercial release of Ecsypno's DAST/IAST offering: Codename SNCR is a highly evolved web application security scanner, utilizing DAST, as well as IAST, techniques -- DAST to analyze server-side behavior from a black-box perspective and DAST & IAST for client-side Javascript environment analysis. In addition, server-side IAST capabilities exist for Ruby web applications, but those are going to be rolled out later on. Editions Codename SCNR comes in 3 editions: Basic -- CLI utilities to manage the scanner engine. + Ruby API for scripting. Pro -- Basic features + a...
Hello all,
There had been a stable/commercial release countdown until the end of this year, however, due to the need for more beta testing and the ongoing search for funding, the countdown has been halted.
It is again uncertain when a commercial release will be available.
Trial version releases and development continue, and your feedback is much appreciated.
Best regards,
Tasos L.